Emerson to buy remaining AspenTech stake in $7.2B deal - Breaking The News

Emerson to buy remaining AspenTech stake in $7.2B deal

27 January

1 min read

EMERSON ELECTRIC

Emerson Electric Co. announced on Monday that it will acquire all shares in Aspen Technology, Inc. it does not already hold for $7.2 billion or $265 per share.

Emerson currently owns a 57% stake in AspenTech and after the completion of the announced transaction, the latter company will become Emerson's wholly-owned subsidiary. The transaction is anticipated to close in the first half of 2025, and AspenTech will then be delisted from the Nasdaq.

"This transaction marks a key milestone in our portfolio transformation, and we are excited to fully integrate AspenTech into Emerson to advance our vision for software-defined control," Emerson President and CEO Lal Karsanbhai commented. "We look forward to offering AspenTech shareholders the opportunity to tender their shares at compelling and certain value while welcoming the AspenTech team into Emerson," he added.

mergers and acquisitions emerson

Related Stocks

Emerson Electric

Samsung finalizes purchase of HVAC firm FlaktGroup

6 November

Samsung Electronics said on Thursday it has completed the acquisition of Germany-based heating, ventilation and air conditioning (HVAC) firm FlaktGroup.The tech giant first announced the deal back in May, when it said it would acquire what it described in today's announcement as "Europe's largest HVAC company" for €1.5 billion from European investment firm Triton. With the deal closed, FlaktGroup's subsidiaries, including Woods Air Movement, which...

Pfizer, Novo Nordisk said to raise bids for Metsera

4 November

Pfizer and Novo Nordisk both raised their bids for US biotech Metsera, escalating one of the fiercest takeover battles in the obesity-drug sector. The Financial Times reported on Tuesday that the improved offers from both companies are expected to be disclosed in a regulatory filing later in the day.Novo Nordisk last week topped Pfizer's earlier agreement with a proposal worth up to $9 billion, triggering a legal and commercial standoff between the two...

Starbucks to sell majority stake of China business to Boyu

3 November

Starbucks announced on Monday it's forming a joint venture with Boyu Capital that will have the alternative investment firm holding up to 60% of the coffee giant's retail operations in China.Boyu will acquire the majority stake based on a cash-free, debt-free enterprise value of approximately $4 billion, with Starbucks retaining 40% and the ability to license the brand and intellectual property to the joint venture. The deal is to be finalized in the second quarter of...

Pfizer files second lawsuit against Metsera, Novo Nordisk

3 November

Pfizer Inc. said on Monday that it filed a second lawsuit against Metsera Inc., its controlling stockholders, and Novo Nordisk A/S, claiming that Novo Nordisk conspired with Metsera and engaged in anticompetitive behavior when it proposed to acquire it. Pfizer first struck a deal to buy Metsera in September, but the obesity drug company then received an offer from Novo Nordisk last week and deemed it superior to Pfizer's. Pfizer then sued both companies on...

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.